CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 189 enrolled
Drug / intervention
diet, fat-restrictedbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000538
NCT00000538Phase 3Completed
CompareCT.gov

Dietary Effects on Lipoproteins and Thrombogenic Activity

University of North Carolina, Chapel Hill·interventional·Posted Oct 28, 1999·Updated Feb 22, 2024

In Brief

A Phase 3 clinical trial evaluating diet, fat-restricted for Cardiovascular Diseases and 6 related conditions. Completed, enrolled 189 participants.

Detailed Summary

To evaluate the effects of carefully controlled diets on lipoproteins and clotting factors in different demographic groups.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Coronary Disease, Coronary Heart Disease Risk Reduction, Heart Diseases, Hyperlipoproteinemia, Myocardial Ischemia, Thrombosis
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 3CompletedFinished
199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartSep 1, 1992
Primary CompletionMay 1, 1995
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 26.7 years ago

Interventions

diet, fat-restrictedbehavioral